48,830
edits
Difference between revisions of "Esophageal adenocarcinoma"
Jump to navigation
Jump to search
Esophageal adenocarcinoma (view source)
Revision as of 16:07, 7 October 2015
, 16:07, 7 October 2015→IHC
(→IHC) |
|||
| Line 99: | Line 99: | ||
*p63 -ve. | *p63 -ve. | ||
*HWMK -ve. | *HWMK -ve. | ||
Others:<ref name=pmid17650224>{{Cite journal | last1 = Liu | first1 = YS. | last2 = Yu | first2 = CH. | last3 = Li | first3 = L. | last4 = Zhang | first4 = BF. | last5 = Fang | first5 = J. | last6 = Zhou | first6 = Q. | last7 = Hu | first7 = Y. | last8 = Li | first8 = YM. | last9 = Jun Gao | first9 = H. | title = Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray. | journal = J Dig Dis | volume = 8 | issue = 3 | pages = 133-8 | month = Aug | year = 2007 | doi = 10.1111/j.1443-9573.2007.00299.x | PMID = 17650224 }}<ref> | |||
*p53 +ve. | |||
*COX-2 +ve. | |||
*p16 +ve - but useless... as frequently positive in precursors. | |||
==Sign out== | ==Sign out== | ||